Evidence map›Paper›PMID 34362714›Full record

ArticleJournal of geriatric oncology2022

Impact of radiotherapy on daily function among older adults living with advanced cancer (RT impact on function in advanced cancer).

Anthony Nehlsen, Parul Agarwal, Madhu Mazumdar, Pinaki Dutta, Nathan E Goldstein, Kavita V Dharmarajan

Open access · greenAbstract read
In one paragraph

Article in Journal of geriatric oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anthony NehlsenDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Parul AgarwalInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Madhu MazumdarInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Pinaki DuttaDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Nathan E GoldsteinBrookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Kavita V DharmarajanDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States of America; Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Geriatrics Research Education and Clinical Center, James J Peters VA Medical Center, Bronx, NY, United States of America. Electronic address: kavita.dharmarajan@mountsinai.org.
Icahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · US

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Deanna L Benson · 2015 to 2026
$35.4M
Residing in the Community with Dementia at the End of Life: Understanding Hospice Use and Residential SettingP30AG028741 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Claire Kathryn Ankuda · 2010 to 2026
$21.9M
Improving Outcomes for Older Adults Undergoing Palliative Radiation TreatmentK76AG068516 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DHARMARAJAN, KAVITA VYAS · 2021 to 2025
$1.2M
NCI NIH HHS P30 CA196521NIA NIH HHS K76 AG068516NIA NIH HHS P30 AG028741
6 · The paper itself

Abstract

backgroundWhile radiation therapy (RT) improves function, and quality of life for patients with advanced cancers, patients frequently experience a period of acute toxicity during which functional abilities may decline. Little is understood about changes in functional outcomes after RT in older adults. This study aims to examine changes in daily function at 1 and 6 months following RT.

methodsWe reviewed the charts of 117 patients who underwent palliative RT on a prospective registry. Activities of daily living (ADL) and instrumental activities of daily living (IADL) scores ranging from 0 to 6 and 0-8, respectively, were collected at baseline, one-month, and six months post-RT. Patients were classified as low deficit for ADL/IADL if they had 0-1 deficits and high deficit if they had 2+ deficits.

resultsOne-hundred seventy RT courses were identified; 99 were evaluable at each time point. The median age was 67 years. At baseline, 29.5 and 29.9% of patients were classified as high-deficit for ADL and IADL functioning, respectively. At one-month, the majority of patients who were low-deficit at baseline remained so for both measures while approximately one quarter of high-deficit patients showed improvement. Most patients identified as low-deficit at one-month remained so at six-months, while no high-deficit patients improved from one- to six-months. Factors associated with high ADL and IADL deficits included: time (six months), increasing age, and Hispanic/other race. Compared to those with ECOG score of 3, patients with lower scores (0-2) had lower odds of high deficit.

conclusionADL and IADL tools may be useful in describing changes in daily function after palliative RT and in identifying groups of patients who may benefit from additional supportive geriatric care interventions.

Indexed as

Activities of Daily LivingNeoplasmsAgedHumansQuality of LifeADLIADLPalliative RTRadiation oncology

Identifiers

PMID34362714
PMCPMC9044675
OpenAlexW3187247229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.